On the fly News and insights, exclusive to thefly.com

EVR

Evercore Partners

$76.89

-1.7 (-2.16%)

, SNY

Sanofi

$42.24

0.13 (0.31%)

10:06
08/14/19
08/14
10:06
08/14/19
10:06

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Evercore Partners (EVR) upgraded to Neutral from Sell at Goldman Sachs with analyst Richard Ramsden saying believes that stronger U.S. large cap deal activity than he previously expected should support Evercore's revenues. 2. Sanofi (SNY) upgraded to Buy from Neutral at UBS with analyst Laura Sutcliffe saying she sees signs of a turnaround for the company and believes its pipeline can fixed ahead of patent expiration. 3. Bristol-Myers (BMY) upgraded to Overweight from Neutral at Atlantic Equities. 4. Horizon Pharma (HZNP) upgraded to Outperform from Market Perform at BMO Capital with analyst Gary Nachman citing the company's "strong" Q2 results driven by Krystexxa. 5. Ferrari (RACE) upgraded to Buy from Neutral at Goldman Sachs with analyst George Galliers citing the company's Q2 results earlier this month. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

EVR

Evercore Partners

$76.89

-1.7 (-2.16%)

SNY

Sanofi

$42.24

0.13 (0.31%)

BMY

Bristol-Myers

$46.64

0.17 (0.37%)

HZNP

Horizon Pharma

$26.49

-0.07 (-0.26%)

RACE

Ferrari

$158.78

-2.31 (-1.43%)

  • 14

    Aug

  • 09

    Sep

  • 13

    Sep

  • 16

    Sep

  • 18

    Sep

  • 23

    Sep

  • 02

    Oct

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.